PrimeraDx is a molecular diagnostics company that has developed, and is commercializing, a novel, game-changing clinical platform that combines PCR with capillary electrophoresis. The result of combining these two well-known technologies into a bench-top instrument is the ability to deliver highly multiplexed and quantitative answers to the clinic. The company’s technology delivers more information to physicians, reduces costs for the lab and enhances patient care by increasing the chances of early disease detection.